Nautilus Biotechnology, Inc. Overview
NAUT market data
Price HistoryDaily closing bars from the ranked market-data provider chain, not a live tape. The most recent bar is the last completed session, so it lags an open market.
NAUT price chart · 1M
- O
- 3.00
- H
- 3.21
- L
- 2.80
- C
- 2.96
- Vol
- 125,475.00
Daily history from Aug 7, 2020
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & PerformanceOpen, range, return and notional-volume facts calculated from daily market bars.
- Open
- $3.00
- Previous Close
- $2.86
- Day High
- $3.21
- Day Low
- $2.80
- 52 Week High
- $4.29
- 52 Week Low
- $0.85
- 7 Day Return
- +8.82%
- 30 Day Return
- +164.29%
- 90 Day Return
- +188.78%
- 1 Year Return
- +118.45%
- Daily Notional Volume
- $371.4K Latest daily bar volume multiplied by its closing price.
Valuation & ProfitabilityProvider-backed valuation, profitability, and range metrics for the selected company. Display-only; never feeds scores or decisions.
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.47 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.74 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.84 – $4.31 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $367.8M · P/B 1.57.
Company NewsSymbol-tagged NewsEvent via getLatestNewsEventsBySymbol (Prisma first, Redis news:latest:v2 fallback). Operator cap 12 / public 10; low-signal filtered, headlines deduped. Display-only—scored signals stay on the separate signals surface.
10 captured
Nautilus to Measure Proteoforms Driving Alzheimer’s Disease and Cancer in ARPA-H-Funded SEEDS ConsortiumGlobenewswire Inc ·
Nautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026Globenewswire Inc ·